Evotec’s multi-modality approach enables fast drug discovery and development solutions. No matter where the project lies on the idea-to-IND continuum, Evotec’s experience supports all activities from target identification through to IND submission, with high-end manufacturing completing this one-stop-shop.

Evotec has in recent years built up extensive expertise and capabilities in biologics. In this regard, Just – Evotec Biologics’ J.DESIGN platform and its expertise in Artificial Intelligence and Machine Learning complements Evotec’s discovery technologies, such as our high-throughput hybridoma-based mAb approach coupled with the Alloy Therapeutics’ ATX Gx™ mice as best-in-class human antibody source.

This comprehensive offering enables our partners to work with one experienced partner, which makes the processes less complicated, more efficient, more productive, less expensive, faster, and finally leading to more flexible ways of discovering, developing and manufacturing biotherapeutics.